| mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
8e-06 |
| mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
| mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-05 |
| mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-05 |
| mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
7e-05 |
| mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
0.21 |
8e-05 |
| mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
| mRNA |
Imatinib |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
0.0001 |
| mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
0.0001 |